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Abstract
Background: Myocardial ischemia/reperfusion injury is the major cause of morbidity and mortality for cardiovascular
diseases. Dopamine D2 receptors are expressed in cardiac tissues. However, the roles of dopamine D2 receptors in
myocardial ischemia/reperfusion injury and cardiomyocyte apoptosis are unclear. Here we investigated the effects of
both dopamine D2 receptors agonist (bromocriptine) and antagonist (haloperidol) on apoptosis of cultured neonatal rat
ventricular myocytes induced by ischemia/reperfusion injury.
Methods: Myocardial ischemia/reperfusion injury was simulated by incubating primarily cultured neonatal rat
cardiomyocytes in ischemic (hypoxic) buffer solution for 2 h. Thereafter, these cells were incubated for 24 h in normal
culture medium.
Results: Treatment of the cardiomyocytes with 10 μM bromocriptine significantly decreased lactate dehydrogenase
activity, increased superoxide dismutase activity, and decreased malondialdehyde content in the culture medium.
Bromocriptine significantly inhibited the release of cytochrome c, accumulation of [Ca
2+]i, and apoptosis induced
by ischemia/reperfusion injury. Bromocriptine also down-regulated the expression of caspase-3 and -9, Fas and Fas
ligand, and up-regulated Bcl-2 expression. In contrast, haloperidol (10 μM) had no significant effects on the
apoptosis of cultured cardiomyocytes under the aforementioned conditions.
Conclusions: These data suggest that activation of dopamine D2 receptors can inhibit apoptosis of
cardiomyocytes encountered during ischemia/reperfusion damage through various pathways.
Background
Dopamine receptors belong to the family of seven trans-
membrane domain G-protein coupled receptors. The
diverse physiological actions of dopamine are mediated
by at least five distinct G protein-coupled receptor sub-
types. Two D1-like receptor subtypes (D1 and D5) activate
adenylyl cyclase. The other receptor subtypes belong to
the D2-like subfamily (D2,D 3,a n dD 4), inhibit adenylyl
cyclase, and activate K
+ channels [1]. The activation of
D2-like receptors decreases intracellular calcium levels.
The underlying mechanisms for this effect may be related
to D2-like receptor-induced activation of potassium cur-
rents and the subsequent alterations in membrane poten-
tial and activation of G proteins. The latter directly
inhibits some calcium channels [2].
After myocardium undergoes severe ischemia, restora-
tion of blood flow is a prerequisite for myocardial salvage.
However, reperfusion may also induce deleterious
changes, such as decreased myocardial contraction and
arrhythmias. These changes occur at the time of reperfu-
sion, termed as ‘’reperfusion injury’’. The mechanisms of
ischemia/reperfusion injury include the production of
reactive oxygen species, abnormal lipid metabolism, and
calcium overload [3]. The resulting alteration in cellular
metabolism and generation of toxic molecules contribute
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characterized by the presence of necrotic and apoptotic
areas in the affected organs [4].
Dopamine receptors exist in cardiac tissue [5]. The
activation of dopamine D2 receptors decreased heart rate,
arterial blood pressure [5]. The expression of dopamine
D2 receptors was reduced in myocardial hypertrophy [6].
Dopamine D2 receptors also had the protective effect on
cerebral ischemia/reperfusion injury [7]. However, the
role of dopamine D2 receptors on myocardial ischemia/
reperfusion injury has not been clear.
In this study, we applied myocardial ischemia/reperfu-
sion injury in neonatal rat cardiomyocytes and explored
the effects of dopamine D2 receptors agonist and antago-
n i s to nc e l la p o p t o s i sa sw e l la st h eu n d e r l y i n gs i g n a l
transduction pathways.
Materials and methods
Materials
Bromocriptine (dopamine D2 receptors agonist), haloper-
idol (dopamine D2 receptors antagonist), and fluo-3/AM
were purchased from Sigma Chemical Co. (St. Louis,
MO, USA). Antibodies against DR2, caspase-3 and -9,
Bcl-2, Fas, Fas ligand (Fas-L), and cytochrome c (Cyt c)
were from Santa Cruz (Heidelberg, Germany). The term-
inal deoxynucleotidyl transferase-mediated dUTP nick
e n dl a b e l l i n g( T U N E L )k i tw a sp u r c h a s e df r o mR o c h e
(Mannheim, Germany). The Western blot kit was from
P r o m e g a( M a d i s o n ,W I ,U S A ) .T h ea n t i b o d ya g a i n s t
b-actin was purchased from Boster (Wuhan, China), and
the antibody against annexin-V was from Promega. Dul-
becco’s modified Eagle’sm e d i u m( D M E M )w a sp u r -
chased from Gibco (Carlsbad, California, USA). Assay
kits for malondialdehyde (MDA), superoxide dismutase
(SOD) and lactate dehydrogenase (LDH) were purchased
from Nanjing Jiancheng Bioengineering Institute (Nanj-
ing, China).
Cell culture and treatment
Primary cultures of neonatal rat cardiomyocytes were
performed as previously described [8]. Newborn Wistar
rats (1-3 days) were used for this study. The rats were
handled in accordance with the Guide for the Care and
Use of Laboratory Animals published by the China
National Institutes of Health. Briefly, hearts from male
Wistar rats (1-3 days old) were minced and dissociated
with 0.25% trypsin. Dispersed cells were seeded at 2×10
5
cells/cm
2 in 60-mm culture dishes with Dulbecco’s modi-
fied Eagle medium (DMEM) supplemented with 10%
fetal bovine serum (FBS) and then cultured in a 5% CO2
incubator at 37°C. Three days after the cells were seeded,
the cultured cardiomyocytes were randomly divided into
the following four groups: control group, cardiomyocytes
continuously cultured for 26 h in DMEM; ischemia/
reperfusion group, cells subjected to 2 h of simulated
ischemia followed by 24 h of reperfusion; bromocriptine
and haloperidol treated groups. In the treatment groups,
10 μM bromocriptine or haloperidol was added to the
culture medium at the beginning of reperfusion. Drugs
were dissolved in pre-warmed medium and added
directly to the culture. For controls, equivalent volumes
of medium were added.
Simulated Ischemia/Reperfusion
The experimental protocol used to simulate ischemia/
reperfusion was a modified version of the method pro-
posed by Han et al. [9]. The cells were treated with
ischemic buffer solution (mM: 5.37 KCl, 0.44 KH2PO4,
136.89 NaCl, 4.166 NaHCO3, 0.338 Na2HPO4,5D - g l u -
cose, pH 7.3-7.4 at 37°C) saturated with 95% N2 and 5%
CO2. The pH was adjusted to 6.8 with lactate to mimic
ischemic conditions. The dishes were put into a hypoxic
incubator that was equilibrated with 1%O2/5%CO2/94%
N2. After hypoxic treatment, the culture medium was
rapidly replaced with fresh DMEM with 10% FBS (10%
FBS/DMEM) to initiate reoxygenation.
Cell viability assay
Cell viability was determined by the 3-(4,5- dimethylthia-
zol-2-yl)-2,5- diphenyltetrazolium bromide (MTT) assay, as
described previously [10]. Cells were cultured in 96-well
plates. MTT (final concentration, 0.5 mg/ml) was added to
each well under sterile conditions, and the plates were incu-
bated for 4 h at 37°C. The supernatant was removed, and
dimethyl sulfoxide (150 μl/well) was added. The plates were
then agitated on a plate shaker. The absorbance of each
well was measured at 490 nm with a Bio-Rad automated
EIA analyser (Bio-Rad Laboratories, Hercules, CA, USA).
The viability of control cells was considered 100%, and the
others were expressed as percentages of control.
Flow cytometric assay
The apoptotic ratio was measured by flow cytometry as
described previously [11,12]. Cells were washed three
times with ice-cold PBS, and then stained with annexin
V-fluorescein isothiocyanate for 15 min at room tem-
perature in 200 μl binding buffer. Next, 300 μlb i n d i n g
buffer was added, and the cells were stained with propi-
dium iodide for 30 min at 4°C. The fluorescence of the
cells was analyzed by flow cytometry. The percentage of
apoptotic cells was determined using Mod Fit LT soft-
ware (Verity Software House Inc., Topsham, ME, USA).
TUNEL staining
Apoptosis was detected by the TUNEL method. In
accordance with the manufacturer’s protocol, cells in
24-well plates were fixed with 4% paraformaldehyde for
30 min at room temperature. After two washes with
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for 2 min at room temperature, then incubated with
50 μl TUNEL reaction mixture for 60 min at 37°C. 3,3’-
Diaminobenzidine was used to generate an insoluble
coloured substrate at the site of DNA fragmentation.
Finally, the cells were counterstained with methyl green
for morphological evaluation and characterisation of
normal and apoptotic cells. All cells were analyzed
under a microscope. The percentage of apoptotic cells
was calculated as the ratio of the number of TUNEL-
positive cells to the total number of cells, counted in
three different random fields.
Transmission electron microscopy
Cells were harvested and fixed with 3.0% glutaraldehyde
and 1.5% paraformaldehyde, washed in phosphate buffer
saline (PBS), and fixed in osmium tetroxide. Then, cells
were dehydrated in an ethanol series, embedded in
epoxy resin and examined under a transmission electron
microscope (JEM-2000EX).
Measurement of [Ca
2+]i
Cultured cardiomyocytes in 96-well plates were loaded
with 10 μM Fluo-3/AM for 60 min at 37°C. Cells were
then rinsed with Ca
2+-free PBS three times to remove
the extracellular fluo-3/AM, and 200 μlD M E Mw a s
added. Excitation was set at 488 nm, and emission was
monitored at 530 nm. Fluorescence images indicating
the [Ca
2+]i were recorded using a confocal laser scan-
ning microscope (Leica, Germany). The loaded cells
were randomly divided into the following three groups:
ischemia/reperfusion group in which cells were incu-
bated for 8 min with DMEM and 60 min with simu-
lated ischemia solution, then reperfused for 30 min with
DMEM; bromocriptine or haloperidol treated groups in
which the similar protocol for the ischemia/reperfusion
group was used but 10 μM bromocriptine or haloperi-
dol was added to the medium at the beginning of
reperfusion.
Detection of cytochrome c release from mitochondrial
To quantify cytochrome c release, western blot analysis
of cytochrome c in the cytosolic fraction was performed
as described previously [13,14]. Briefly, cells were har-
vested, washed twice with ice-cold PBS, and incubated
in ice-cold Tris-sucrose buffer (0.35 mM sucrose, 10
mM Tris-HCl at pH 7.5, 1 mM EDTA, 0.5 mM dithio-
threitol, 0.1 mM phenylmethylsulphonyl fluoride). After
a 40 min incubation, cells were centrifuged at 1000×g
for 5 min at 4°C and the supernatant was further centri-
fuged at 40,000×g for 30 min at 4°C. The supernatant
was retained as the cytosolic fraction and analyzed by
Western blot with a primary rat anti-cytochrome c
monoclonal antibody and a secondary goat anti-rat
immunoglobulin G (Promage). b-actin expression was
used as the control.
Detection of the expression of DR2, caspases-3 and -9,
Fas, FasL, and Bcl-2 by Western blot
Total proteins were prepared from neonatal rat myocytes
as described previously [15,16]. To each lane of a 10%
sodium dodecyl sulfate-polyacrylamide gel electrophor-
esis, 20 μg of total protein was applied, electrophoresed
and transferred to a polyvinylidene fluoride membrane.
Membranes were blocked with Tris-buffered saline con-
taining 5% non-fat milk at 37°C for 1 h, then incubated
overnight at 4°C with anti-DR2 (1:500), anti- caspase-3
(1:500), anti- caspase -9 (1:500), anti-Fas (1:500), anti-
Fas-L (1:500), anti-Bcl-2 (1:500) antibodies (from Santa
Cruz of Heidelberg, Germany). The membrane was then
washed three times in 1×Tris-buffer saline-Tween20
(TBST) buffer and incubated with anti-IgG antibody con-
jugated with alkaline phosphatase diluted 1:1000 in TBST
for 1 h at room temperature. Antibody-antigen com-
plexes were detected using Western Blue Stabilized Sub-
strate for alkaline phosphatase. b-actin expression was
used as the control. The intensities of the protein bands
were quantified by a Bio-Rad ChemiDoc™ EQ densit-
ometer and Bio-Rad Quantity One software (Bio-Rad
Laboratories).
Measurement of MDA level, LDH and SOD activities
The level of malonaldehyde (MDA) in the culture med-
ium was detected with thiobarbituric acid-reactive sub-
stances assay and the experiment was carried out with a
commercial kit (Jiancheng, Nanjing, China) according to
manufacturer’s introduction. MDA values were
expressed as nmole per gram protein.
Superoxide dismutase activity (SOD) in the culture med-
ium was determined by monitoring the inhibition of the
autoxidation of hydroxylamine using previously described
methods [17]. The protein in the culture medium was
detected by the Coomassie brilliant blue method.
The activity of Lactate dehydrogenase activity (LDH)
in the culture medium, as an indicator of cytotoxicity,
was measured spectrophotometrically with a commer-
cially available assay kit (Jiancheng Bioengineering
Institute).
Table 1 The levels of LDH and MDA as well as SOD
activity in Culture medium from different groups
Groups LDH (U/mL) SOD (U/mL) MDA (nmol/mL)
Control 29.7 ± 2.2 36.1 ± 1.2 8.8 ± 0.6
I/R 56.4 ± 1.8
a 30.4 ± 2.3
a 17.4 ± 1.2
a
Bromocriptine 44.3 ± 2.3
c 36.6 ± 2.1
c 14.2 ± 0.8
b
Haloperidol 58.1 ± 1.9 31.7 ± 2.1 17.2 ± 1.3
Data are means ± S.E.M. of 10 determinations.
aP < 0.01 versus control;
bP <
0.05,
cP < 0.01 versus ischemia/reperfusion (I/R).
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Figure 1 The effects of dopamine D2 receptor agonist and antagonist on apoptosis of neonatal cardiomyocytes exposed to simulated
ischemia/reperfusion. Cardiomyocytes were subjected to 2 h of simulated ischemia, and then incubated under normal conditions in the
presence or absence of 10 μM bromocriptine or haloperidol for 24 h. The data are means ± S.E.M. of five determinations.
▼▼P < 0.01 versus
control;
★★P < 0.01 versus ischemia/reperfusion. (A) MTT assay for cell viability. (B) DNA fragmentation determined by quantitative TUNEL
staining of apoptotic cardiomyocytes. (C) Flow cytometry analysis.
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All experiments were performed at least three times for
each determination. Data were expressed as mean ± S.E.
M. Comparisons among the groups were performed by
KruskaleWallis one-way ANOVA. Values of < 0.05 were
considered as significant.
Results
Measurement of LDH, SOD and MDA levels
In the ischemia/reperfusion group, the levels of LDH and
MDA were significantly increased but SOD activity was
decreased compared with the control group (P < 0.01). In
the bromocriptine-treated group, LDH and MDA levels
were significantly decreased but SOD activity was increased
(P < 0.05 or P < 0.01 versus ischemia/reperfusion group).
No changes of LDH, MDA and SOD were observed in the
haloperidol-treated group in comparison with that in ische-
mia/reperfusion group (P > 0.05) (Table 1).
Cell viability
MTT analysis showed that the viability of the bromo-
criptine-treated cells (81% ± 3.0%) was significantly
higher than that of the ischemia/reperfusion group
(74% ± 3.3%) (P < 0.01). However, haloperidol
treatment had no effect on cell viability (73% ± 3.8%)
compared with the ischemia/reperfusion group (P >
0.05) (Figure 1A).
Rate of apoptotic cell
Only 6 ± 0.7% TUNEL positive nuclei were detected in
control cells at the end of the experiment, and ische-
mia/reperfusion significantly increased the percentage of
apoptotic cells to 18 ± 1.6% (P < 0.01 versus control
group). Compared with the ischemia/reperfusion group,
bromocriptine treatment reduced the percentage of
TUNEL-positive cells to14 ± 1.0% (P < 0.01). The per-
centage of TUNEL-positive cells in the haloperidol-trea-
ted group was not significantly different from that in the
ischemia/reperfusion group (P > 0.05) (Figure 1B).
Flow cytometry analyses detected few apoptosis in the
control group. Apoptosis was significantly increased when
cells were exposed to ischemia/reperfusion (P < 0.01 ver-
sus control group), and pretreatment with bromocriptine
decreased the apoptosis rate significantly (P < 0.01 versus
ischemia/reperfusion group). In contrast, pre-treatment
with haloperidol did not significantly affect the apoptosis
induced by ischemia/reperfusion (P > 0.05 versus ische-
mia/reperfusion group) (Figure 1C).
AB
C D
Figure 2 Ultrastructural changes in cardiomyocytes. (A) Control group; (B) ischemia/reperfusion group; (C) The bromocriptine-treated group;
and (D) The haloperidol-treated group (magnification ×8000). In the ischemia/reperfusion group, nuclear chromatin margination, aggregation,
and condensation and mitochondrial swelling and vacuolisation were observed. There was no significant change in nuclear chromatin in the
control group. Cardiomyocyte injury was lessened in the bromocriptine-treated group compared with the ischemia/reperfusion group but was
not significantly changed in the haloperidol-treated group.
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Figure 3 Changes of intracellular free calcium concentration. (A) Fluorescent images of cardiomyocytes incubated in DMEM, or incubated in
simulated ischemia solution and re-incubated in DMEM in the presence or absence of 10 μM bromocriptine or haloperidol, respectively. (B)
Changes in fluorescent intensities of intracellular Ca
2+ in different treatment groups were recorded continuously with confocal laser scanning
microscopy. Intracellular Ca
2+ was recorded for a total of 98 min.
★P < 0.05 versus ischemia/reperfusion.
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The results of transmission electron microscopy
showed that structure of nuclear membrane was clear
with even distribution of nuclear chromatin, and mito-
chondria structure was intact in the control group.
Morphological change of apoptosis, including nuclear
pycnosis, nuclear chromatin margination, aggregation
and condensation, and swelling and vacuolization of
mitochondria were observed in the ischemia/reperfu-
sion and the haloperidol-treated groups. Compared
with ischemia/reperfusion, these morphological
changes were less severe in the bromocriptine-treated
group (Figure 2).
Measurement of [Ca
2+]i
The concentration of intracellular free calcium was
recorded continuously by laser confocal scanning micro-
scopy. The average cytosolic Ca
2+ concentration in a
single cell was determined using the fluorescent probe
fluo-3/AM, which is a sensitive Ca
2+ probe. The Ca
2+
peak was increased in the ischemia/reperfusion group
(P < 0.01 versus control group). When bromocriptine
was added to the medium at the beginning of reperfu-
sion, the Ca
2+ peak was significantly decreased com-
pared with the peak in the ischemia/reperfusion group
(P < 0.05 versus ischemia/reperfusion group). However,
haloperidol did not alter ischemia/reperfusion-induced
change in the Ca
2+ peak (P > 0.05) (Figure 3).
Expression of DR2
The expression of DR2 was increased markedly in the
ischaemia/reperfusion group compared to the control
group (P < 0.01) (Figure 4).
Expression of Bcl-2
The expression of Bcl-2 was increased significantly in
the ischemia/reperfusion group compared with the con-
trol group (P < 0.01). However, Bcl-2 expression was
increased more in the bromocriptine group than the
ischemia/reperfusion (P < 0.01). In the haloperidol-trea-
ted group, Bcl-2 expression was similar to that of the
ischemia/reperfusion group (Figure 5C).
Expression of Caspases-3 and -9, Fas, Fas-L, and release
of Cyt c
Compared with the control group, the expression of cas-
pases-3 and -9, Fas, Fas-L, and the mitochondrial release
of cytochrome c were significantly increased in the
ischemia/reperfusion group (P < 0.01), and bromocrip-
tine reversed these increases (P <0 . 0 5o rP <0 . 0 1v e r -
sus ischemia/reperfusion group). In contrast, the
expression of caspases-3 and -9, Fas, Fas-L, and cyto-
chrome c release were not changed obviously in the
haloperidol-treated group compared with the ischemia/
reperfusion group (P > 0.05) (Figure 5A-B, 6A-C).
Discussion
Cardiomyocyte apoptosis is a major pathogenic mechanism
underlying myocardial ischemia/reperfusion injury [18].
However, very little is known about the effect of dopamine
D2 receptors activation or suppression on cardiac apopto-
sis-induced by ischemia/reperfusion injury. In this paper,
we examined whether bromocriptine (a selective agonist of
dopamine D2 receptors) or haloperidol (dopamine D2
receptors antagonist) play a role in cardiomyocyte apopto-
sis induced by simulated ischemia/reperfusion injury. The
results showed that bromocriptine significantly decreased
LDH and MDA levels, increased SOD activity, reduced
morphological injury of cardiomyocytes, increased the cell
viability, and decreased apoptosis. We also observed that
DR2 expression was increased markedly during ischaemia/
reperfusion. These results suggested that activation of
dopamine D2 receptors significantly inhibit apoptosis
induced by ischemia/reperfusion injury.
Intracellular calcium is regarded as a trigger for cardi-
omyocyte apoptosis in ischemia/reperfusion injury.

Figure 4 Expression of DR2. The intensity of each band was
quantified by densitometry, and data were normalized to the b-
actin signal. The expression levels in the control group were
considered the basal levels, and the others are expressed as fold
change from the control group. The fold change values represent
the means ± S.E.M. of five determinations.
▼▼P < 0.01 versus control.
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Figure 5 Expression of caspase-9 (A), release of cytochrome c (B), and expression of Bcl-2 (C) determined by Western blot analysis.
The intensity of each band was quantified by densitometry, and data were normalized to the b-actin signal. The expression levels in the control
group were considered the basal levels, and the others are expressed as fold change from the control group. The fold change values represent
the means ± S.E.M. of five determinations.
▼▼P < 0.01 versus control;
★★P < 0.01 versus ischemia/reperfusion.
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free radical generation, damage mitochondria, release
apoptotic promoters, and activate the caspase cascade
[19]. It was reported that D2-like receptors might sup-
press activation of adenylate cyclase, down-regulate cyc-
lic AMP (cAMP) levels, then inhibit the activation of
protein kinase A (PKA), inhibit L-type voltage-gated
channels, and finally decrease [Ca
2+]i [20]. Our study
observed that [Ca
2+]i was increased significantly after
ischemia/reperfusion, while bromocriptine markedly
decreased [Ca
2+]i compared with the ischemia/reperfu-
sion group. Moreover, bromocriptine increased SOD
activities and decreased MDA contents. These results
indicate that activation of dopamine D2 receptors may
play an anti-apoptotic role by inhibiting the calcium
overload and scavenging free radical.
A
B
C
Figure 6 Expression of Fas (A), Fas-L (B) and caspase-3 (C) determined by Western blot analysis. The intensity of each band was
quantified by densitometry, and data were normalized to the b-actin signal. The expression levels in the control group were considered the
basal levels, and the others are expressed as fold change from the control group. The fold change values represent the means ± S.E.M. of five
determinations
. ▼▼P < 0.01 versus control;
★P < 0.05,
★★P < 0.01 versus ischemia/reperfusion.
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One is the mitochondrial or intrinsic pathway, which is
initiated by stress signals through the release of cyto-
chrome c from the mitochondrial intermembrane space.
This triggers cytosolic caspase-3 activation through for-
mation of the cytochrome c/Apaf-1/caspase-9- contain-
ing complex apoptosome. The other one is the so-called
extrinsic pathway, which is a receptor mediated cell
death initiation process. Stimulation of death receptors of
the tumor necrosis factor receptor superfamily (Fas and
TNF receptor) results in activation of the initiator cas-
pase-8, which can propagate the apoptosis signal by
direct cleavage of downstream effector caspases such as
caspase-3[21-23]. Caspase-3, a central ‘executioner’ or
‘downstream’ caspase, is an important effector molecule
in apoptosis [24]. Bcl-2, a potent inhibitor of apoptosis,
can prevent disruption of the mitochondria and the sub-
sequent release of cytochrome c, and caspase activation
[25]. It is well-known that ischemia/reperfusion can
cause increase of oxygen free radical and intracellular cal-
cium overload, which induce apoptosis by mitochondrial
permeability transition pore opening and increase of Fas/
Fas-L (TNF-a) transcription through activation of
MAPK-NF-B pathway.
Although the effective concentration of bromocriptine
to protect reperfusion-induced cell apoptosis is 60 to
100 fold higher than the peak therapeutic plasma con-
centration, the inhibition of reperfusion-induced
increase of cellular calcium by bromocriptine could be
antagonized by 10 μM haloperidol. This result indicate
that the inhibition of hypoxia/reperfusion induced apop-
tosis by bromocripline may be related to the stimulation
of dopamine D2 receptor.
Our experimental results showed that bromocriptine
down-regulated the expression of pro-apoptotic genes
(caspase-3 and -9, Fas and Fas-L), decreased release of
cytochrome c, and increased the expression of anti-
apoptotic gene (Bcl-2). These data suggest that the acti-
vation of dopamine D2 receptors inhibit apoptosis by
down-regulating both cytochrome c-caspase-3 and Fas/
Fas-L signaling pathways.
Interestingly, we found that haloperidol had no effect
on the aforementioned indices related to apoptosis,
compared with the ischemia/reperfusion group. The
precise role of dopamine D2 receptor inhibition in apop-
tosis induced by ischemia/reperfusion need to be
explored further.
Conclusions
Our study indicated that activation of dopamine D2
receptors could inhibit apoptosis by reducing calcium
overload, scavenging free radical, down- regulating cyto-
chrome c-caspase-3 mitochondrial and Fas/Fas-L death
receptor signaling pathways. Attenuation of apoptosis by
dopamine D2 receptors activation may open a new ther-
apeutic window in the treatment of ischemia/reperfusion
injury.
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